Consultation Summary: Strategies to Increase Hepatitis C Treatment Within ADAPs

Consultation Summary: Strategies to Increase Hepatitis C Treatment Within ADAPs

November 2016
HRSA HIV/AIDS Bureau (HAB)

Consultation meeting regarding strategies to increase hepatitis C (HCV) treatment within ADAPs. Report features:

  • participants in the consultation
  • best practices in ADAP HCV treatment utilization
  • round-robin discussions
  • recommendations
  • summary tables of ADAP formulary inclusion of directly-acting antiviral (DAA) HCV medications and coverage policies